Molecules (Basel, Switzerland)HumansAlzheimer DiseaseNeuroprotective AgentsDrug DevelopmentAnimals
Experimental Models and Translational Strategies in Neuroprotective Drug Development with Emphasis on Alzheimer's Disease.
Przemysław Niziński, Karolina Szalast, Anna Makuch-Kocka, Kinga Paruch-Nosek, Magdalena Ciechanowska, Tomasz Plech
Published: 202610.3390/molecules31020320
Abstract
Neurodegenerative diseases (NDDs), including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), are becoming more prevalent and still lack effective disease-modifying therapies (…
Preview only. Read the full abstract at the source